Tag: endoAVF
Renal Interventions’ top 10 stories of May 2024
In May, we saw revolutionary new devices, trials that show promise for the future of chronic kidney disease (CKD), and the role of medication...
The role of the EVA meeting and what we are trying...
Dimitrios Karnabatidis, Konstantinos Katsanos, and Panos Kitrou (University of Patras, Patras, Greece), the directors of the Endo Vascular Access (EVA) meeting, together write about...
CX 2024 debates success of the “endoAVF experiment”
The Vascular Access Controversies Masterclass at this year’s Charing Cross (CX) International Symposium (23–25 April, London, UK) was the setting for a Great Debate...
“We know which DCB to use”—but many other questions remain in...
A first-time presentation of five-year data from the IN.PACT AV Access study evaluating the IN.PACT AV (Medtronic) drug-coated balloon (DCB) today led principal investigator...
ASDIN president outlines the Society’s achievements from the past two years...
At this year’s American Society of Diagnostic and Interventional Nephrology (ASDIN) annual scientific meeting (23–25 February 2024, New Orleans, USA), outgoing president Vandana Dua...
Renal Interventions’ top 10 stories of February 2024
February was a month of trials beginning enrolment, novel technologies, and treatment protocols, with Gianmarco Falcone emphasising the need for a full protocol and...
A full protocol and multidisciplinary team are needed for endoAVF to...
At the most recent Paris Vascular Insights (PVI) meeting (8–10 November 2023, Paris, France), Renal Interventions spoke to Gianmarco Falcone (Azienda Ospedaliero Universitaria Careggi,...
Kate Steiner
From choosing her specialty to competing in dressage, interventional radiology (IR) lead at East and North Herts NHS Trust (Stevenage, UK) Kate Steiner speaks...
Innovation in dialysis access: From vision to reality
Ali Kordzadeh is a consultant vascular and access surgeon at Mid and South Essex NHS Foundation Trust (UK) and a visiting professor at Anglia...
US survey shows lack of kidney patient awareness of minimally invasive...
A survey recently conducted by Medtronic and the US National Kidney Foundation (NKF) found that patients undergoing haemodialysis lack awareness about minimally invasive treatment...
Pathfinder Medical and Imperial College London awarded Innovate UK Smart grant...
Pathfinder Medical has been awarded a Smart grant for a £1.1 million (US$1.4 million) project by Innovate UK, the UK's innovation agency. A press...
“EndoAVF 2.0” projects evaluated in CX debate
The advent of endovascular arteriovenous fistula (endoAVF) creation with the development of the Ellipsys (Medtronic) and WavelinQ (BD) systems marks a “major innovation in...
Renal Interventions’ top 10 stories of May 2023
May saw comprehensive coverage of the 2023 Charing Cross Symposium (CX 2023; 25–27 April, London, UK), with deep dives into cost effectiveness and endovascular...
Renal Interventions 8
Highlights:
New UK Kidney Association guidelines on vascular access detailed in conversation with two of its authors, Damien Ashby and Catherine Fielding
CX Symposium...
EndoAVF maturation rates “similar” to surgical but bolstered by reinterventions
Published in the Journal of Vascular Surgery (JVS), new research by Theodore H Yuo (University of Pittsburgh Medical Center, Pittsburgh, USA) and others has...
Next-generation endoAVF technologies promise to expand candidate patient population
Endovascular arteriovenous fistula (endoAVF) creation marks a “major innovation in dialysis access”, while a “mounting evidence base” demonstrates their high functional patency rates. Now,...
Renal Interventions’ top 10 stories of April 2023
April was a month of dialysis analysis and AVF updates, with end-stage renal disease (ESRD) also associated with adverse limb events in a new...
Neghae Mawla
Neghae Mawla (Dallas Nephrology Associates, Dallas, USA) of the American Society of Diagnostic and Interventional Nephrology (ASDIN) is an interventional nephrologist (IN) and a...
Thrombosis focus and dialysis discussion at first CX renal interventions session
The renal interventions session at Charing Cross (CX) Symposium 2023 (25–27 April, London, UK) yielded a rich vein of education and audience participation on...
EndoAVF found usually less cost effective compared with sAVF
The Society for Clinical Vascular Surgery (SCVS) 50th Annual Symposium (25–29 March, Miami, USA) hosted a series of abstract presentations. Among them was one...
Significant untapped areas for research and education in the endoAVF field
Robert Jones (Birmingham, UK), interventional radiologist and president of the Vascular Access Society of Britain and Ireland (VASBI), tells Renal Interventions at the Endovascular...
Vascular access creation: EndoAVF keeps future options open, but is not...
Based on over four years of experience in a single centre, Robert Shahverdyan (Asklepios Klinik Barmbek, Hamburg, Germany) claims that endovascular arteriovenous fistula (endoAVF)...
Charmaine Lok
Equally at home on the ward seeing patients, at study sites conducting research, and travelling the world for voluntary medical missions, Charmaine Lok has...
Largest patient series to date reinforces 4Fr WavelinQ system’s potential in...
A multicentre experience with the 4 French (4Fr) WavelinQ endoAVF system (BD) has found that the device is safe and effective, bolstering existing evidence...
Dialysis tech firm Pathfinder Medical secures £8.5 million
Pathfinder Medical, which has developed a proprietary technology to guide and accurately align catheters in endovascular procedures allowing clinicians to make connections across blood...
Ellipsys™ Vascular Access System provides consistently great outcomes for AV fistula...
Alexandros Mallios (Paris, France) and Robert Shahverdyan (Hamburg, Germany) talk to Vascular News about some of the benefits of the Ellipsys™ Vascular Access System...
Benefits of percutaneous fistula creation further bolstered by five-year Ellipsys data
The Ellipsys vascular access system (Avenu Medical/Medtronic) can be used to easily and safely create durable percutaneous arteriovenous fistulas (pAVFs) for haemodialysis—with new, long-term...
Cannulation difficulties among biggest hurdles for device-created fistulas
Difficulties in cannulation are currently as pressing as any other challenge facing patients who undergo device-enabled arteriovenous fistula (AVF) creation for dialysis. This was...
The WavelinQ™ EndoAVF System takes an innovative approach in creating endovascular...
NOTE: This advertorial is ONLY available to watch in selected countries and geographies
This advertorial, sponsored by BD, is intended for readers in the...
Fist Assist device achieves significant perforator vein dilation for improved endoAVF...
Fist Assist Devices has announced that data associated with the p-FACT cohort, a subset of the recently completed, non-significant risk Fist Assist clinical trial...
CX 2020 LIVE: Vascular Access session showcases new technologies, while debate...
The CX 2020 LIVE Vascular Access Consensus session sparked global interest, with chair Nick Inston (Birmingham, UK) and moderator Domenico Valenti (London, UK) taking...